Chromosomal abnormality scores unlock path to personalized immunotherapy
In a newly published article in Nature Genetics, researchers from the University of Chicago have identified tumor aneuploidy – an imbalance in the number of chromosomes – as a powerful biomarker associated with resistance to immunotherapy across cancer …